Skip to main content

What Medtronic's Quarter ended Jul 31, 2026 10-Q says: 4 signals

Medtronic filed its latest 10-Q with the SEC on Sep 3, 2026. It discusses acquisition completed, product liability and restructuring.

Public (MDT)Medical Equipment Manufacturing10,000+ employeesmedtronic.comLinkedIn

Get Medtronic's live signals in Claude or ChatGPT, or by API

AskWhat changed at Medtronic this week? Use Autobound signals for medtronic.com.
Filed
Sep 3, 2026
Period
Quarter ended Jul 31, 2026
Filings
2
Signals
9

Source: Autobound Signal API · 99 signals tracked for Medtronic · updated

10-Q · latest 9

What Medtronic's 10-Q filings say

  1. 10-Q · Quarter ended Jul 31, 2026

    Filed · 4 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jan 23, 2026

    Filed · 5 signals

    SEC EDGAR

Earnings calls

Medtronic earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Revenue up 13.7% to $9.8B with 23.7% operating marginReported enterprise revenue reached $9.8B, advancing 13.7% organically with adjusted EPS of $1.45. Operating margin rose 10 basis points to 23.7% and gross margin reached 65.2%. Growth was supported by strong procedure volumes across end markets, including 16% growth in the U.S. and 12% internationally.
Full-year organic revenue guidance raised to 7.25% to 7.75%Fiscal year 2027 organic revenue growth outlook was lifted by 50 basis points to 7.25%-7.75% following Q1 outperformance. Full-year adjusted EPS guidance was also raised to $5.94-$6.00, with operating profit expected to increase 10% and operating margin projected to expand 50 basis points.
Separation of MiniMed diabetes business scheduled before fiscal year-endMedtronic is moving forward with the planned separation of its MiniMed diabetes business to create two focused entities with independent capital allocation strategies. Deconsolidating the lower-margin consumer-focused unit is projected to lift enterprise gross margin by 50 basis points and operating margin by roughly 100 basis points.
Rationalized over 9,000 SKUs delivering 50 basis point cost savingsMedtronic eliminated more than 9,000 SKUs during Q1 as part of an operational simplification and COGS efficiency initiative across global operations and supply chains. Net of inflation, operational cost-out programs generated 50 basis points of gross margin improvement, supporting full-year operating margin expansion targets of approximately 50 basis points.
Strategic investment and international distribution agreement for Sentire Surgical SystemMedtronic established an international distribution agreement and strategic investment with Cornerstone Robotics for its Sentire Surgical System in select markets outside the U.S. The platform complements Hugo to scale Medtronic's multi-platform soft-tissue robotics portfolio, with revenue lift and margin impact expected to begin in fiscal 2028.
Unfavorable product mix creates 50 basis point gross margin dragProduct and capital mix created a 50 basis point headwind on gross margin in Q1, driven predominantly by rapid initial capital placements in CAS (Affera systems) and lower-margin contributions from the Diabetes segment. Management anticipates this dilution will decline over time as higher-margin consumable catheter sales pull through and the MiniMed divestiture closes.

Signal API · MCP

Track Medtronic with the Signal API

One POST /v1/companies/enrich call with medtronic.com returns Medtronic 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"medtronic.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Medtronic 10-Q

When did Medtronic file its latest 10-Q?
Medtronic filed its latest 10-Q (Quarter ended Jul 31, 2026) on Sep 3, 2026. The one before it was filed on Feb 24, 2026.
What did Medtronic disclose in its latest 10-Q?
From the filing dated Sep 3, 2026: Medtronic completes acquisitions of CathWorks, Scientia Vascular, and SPR Therapeutics across multiple divisions
What did Medtronic say on its recent earnings calls?
Q1 FY2027: Revenue up 13.7% to $9.8B with 23.7% operating margin (dated Sep 1, 2026).
Where can I read Medtronic's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/mdt-20260731.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →